The SAPA-CT 11th Annual Meeting took place at Yale University on December 7, 2024, under the theme “New Era of Innovation in Biomedicine.” The event was packed with insightful discussions on:
🔹 Cutting-edge drug development technologies
🔹 AI-driven research
🔹 Career development workshops
🔹 Biomedical innovation pitch competitions
💁Our CEO, Daozhan Yu, presented groundbreaking advancements in AAV vector design and therapeutic applications, emphasizing their transformative potential in gene therapy.💁Our CTO, Qizhao Wang, showcased AAVnerGene’s comprehensive AAV systems, especially AAVone, highlighting its scalability and precision-engineered capabilities. Together, they explored innovative strategies to overcome current challenges in gene therapy, including optimizing capsid libraries and improving targeted delivery. The discussions highlighted AAVnerGene’s commitment to advancing gene therapy technology for better clinical outcomes
Th event brought together global leaders, innovators, and students, fostering collaborations that drive the biotech and medicine industries forward. Key moments included inspiring keynote speeches, award ceremonies, and the announcement of Sidi Chen as President-Elect.
💡 With 20+ years of expertise in AAV gene and cell therapy, AAVnerGene delivers trusted, high-quality solutions tailored to your needs:
✅ AAV Vector Design and Optimization – Boost efficiency
✅ Custom AAV Packaging Services – Lower your costs
✅ Comprehensive AAV Analysis – Minimize risks & ensure QA
✅ Capsid Libraries Construction & Production – Diverse libraries for effective screening
✅ Capsid Selection & Directed Evolution – Accelerate your pipeline
✅ Experiment Consultation & Strategic Support – Tailored guidance for optimal outcomes
🌐 We deliver products worldwide, ensuring seamless logistics and reliable support wherever you are.
Let’s explore how we can collaborate—reach out today!
📭：customer@aavnergene.com
🌐：www.aavnergene.com
☎️：+1 301-605-7502
📍 : 9620 Medical Center Dr, Suite 100, Rockville, MD 20850